Home/Filings/4/0000905148-25-003782
4//SEC Filing

Walker Marlan D 4

Accession 0000905148-25-003782

CIK 0000025743other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 4:16 PM ET

Size

5.2 KB

Accession

0000905148-25-003782

Insider Transaction Report

Form 4
Period: 2025-11-03
Walker Marlan D
Chief Executive Officer
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2025-11-03+67,49267,492 total
    Exercise: $1.15From: 2025-11-03Exp: 2035-11-03Common Stock (67,492 underlying)
Footnotes (1)
  • [F1]Underlying shares each vested on November 3, 2025.

Documents

1 file

Issuer

TherapeuticsMD, Inc.

CIK 0000025743

Entity typeother

Related Parties

1
  • filerCIK 0001820187

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:16 PM ET
Size
5.2 KB